Group items tagged

Redsa is a technology provider focused on the health sector that facilitates the exchange of clinical and administrative information across its MediCloud network. This exchange is enabled by an interoperable platform in which all members of the sector interact and exchange information (insurers, hospitals, clinics, laboratories and government). Redsa has over 20 years of experience in the health sector and currently manages a network that integrates more than 40,000 health providers, 300 laboratories, 100 hospitals and 15 insurance companies.

"Medical Devices Survey 2013-2014: Market Trends, Marketing Spend and Sales Strategies in the Global Medical Devices Industry" is a new report by canadean that analyzes how medical devices industry supplier companies' media spend, marketing and sales strategies and practices, and business planning are set to change in 2013-2014.

"Global Medical Devices Survey 2013-2014" is a new report by ICD Research that analyzes how medical devices industry companies' procurement expenditures, business strategies, and practices are set to change in 2013-2014.

"Bacterial Partnering Terms and Agreements"provides a detailed understanding and analysis of how and why companies enter bacterial partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors bacterial technology.

Cough, Cold and Allergy (Hay Fever) Remedies in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

"Booming Medical Tourism in Malaysia"is studied thoroughly on various grounds. Comprehensive study of the current market scenario along with the existing medical infrastructure covering hospitals, healthcare human resources and technological developments has been done.

Tech innovation in the healthcare industry is seeing some exciting developments that are changing lives and the latest of these is an ATM pharmacy.

Tech innovation in the healthcare industry is seeing some exciting developments that are changing lives and the latest of these is an ATM pharmacy.

Scientific Regulatory writing is a complex process due to its dossier size, data complexity, and submission deadlines and it requires specialized domain-specific knowledge, understanding of drug development process, pharmacology, statistical and writing skills to develop superior regulatory documents as per the exact requirements of the regulatory authority. Besides, the scientific writer must be familiar with technical guidelines prevailing in countries like European Union (EU), USA, Japan that includes ICH E3 to write clinical study reports, periodic safety reports (ICH E2C), publication guidelines (e.g. CONSORT, STROBE, PRISMA), the International Committee of Medical Journal Editors (ICMJE) guidelines for manuscripts.

Here's the timeline of how the Coronavirus outbreak evolved from Wuhan city in China and spreading its tentacles across the world.

Multiple myeloma is a type of cancer that forms a type of white blood cell called a plasma cell. In multiple myeloma, cancerous plasma cells gather around the bone marrow and crowd out healthy cells. Some of the most common symptoms of multiple myeloma are pain in the back or bones, anemia, fatigue, and kidney damage. Multiple myelomas can be identified by a biopsy, which is conducted when tissue samples from the affected area are taken and examined under a microscope. When multiple myelomas are detected on an examination, it is typically very easy to remove them with a scalpel, and in many cases, surgeons will opt to remove only one lobe of tissue at a time. There has the development of various multiple myeloma drugs over the years with key industry players being involved in continuous research and development activities. Selinexor is one of the latest U.S. FDA-approved drug for multiple myeloma and is used to treat people suffering from relapsed or refractory disease. Furthermore, Ixazomib is the first and only oral proteasome inhibitor, indicated for multiple myeloma treatment. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/multiple-myeloma-drugs-are-getting.html

Hereditary Angioedema is a disease, which is the result of genetic mutation, within the families with higher genetic activity. It is not contagious to others. The cause of heredity is still unknown but it is believed that the disease is related to the immunological mechanism. Hereditary Angioedema is a chronic non-inflammatory disease that affects millions of people around the world. Symptoms include persistent dryness of the skin, scalp itching, inflammation, rash, severe skin peeling and cracking, bleeding and hives, pain in the area where the skin is affected. As a part of the diagnosis, a medical practitioner who is experienced in treating hereditary angioedema must do a skin biopsy to find out the exact cause of allergic skin reaction. Rising awareness regarding hereditary angioedema is expected to drive growth of the global hereditary angioedema market during the forecast period. Hereditary angioedema or also referred to as HAE has received significant attention in the recent past as government and non-government organizations across the globe are focused on increasing public awareness to improve diagnosis and enhance the treatment. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/hereditary-angioedema-market-to-witness.html